Tempest Therapeutics TPST
NASDAQ TPST
$0.81 -0.03 (-3.38%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) EV to FCF (2018)

Updated

Tempest Therapeutics' (TPST) EV to FCF was 42.20 for Q3 2018.

Analysis

Tempest Therapeutics (TPST) EV to FCF (2018) Analysis & Trends

Over the twelve months ended Sep 30, 2018, Tempest Therapeutics' EV to FCF came in at -20.08.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Tempest Therapeutics 4.09 Mn -26.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 42.20
API Access

Tempest Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=TPST&period=max&api_key=YOUR_API_KEY